share_log

Windtree Therapeutics Q4 2023 GAAP EPS $(0.95) Misses $(0.94) Estimate

Moomoo 24/7 ·  Apr 17 08:19

Windtree Therapeutics (NASDAQ:WINT) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.94) by 1.06 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment